Skip to content
Open access

Integrative multi-omics and experimental validation identify SERINC2 as a ferroptosis-related biomarker in idiopathic pulmonary fibrosis

Sep 2026 · Clinical and Experimental Medicine (Testo stampato) · 0 citations

TL;DR

It is suggested that SERINC2 may serve as a potential diagnostic biomarker and therapeutic target, providing new insights into the pathogenesis and potential treatment of IPF.

Abstract

Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal lung disease with limited therapeutic options. Ferroptosis, an iron-dependent cell death, has been implicated in various fibrotic diseases, but its role in IPF remains unclear. This study integrates spatial transcriptomics, single-cell RNA sequencing, and bulk RNA-seq to explore ferroptosis in IPF. A ferroptosis scoring model and machine learning algorithms identified SERINC2 as a key gene upregulated across all datasets, with high expression in basal cells. Further analysis revealed that SERINC2⁺ basal cells are involved in key signaling pathways, such as Wnt and NT, and exhibit active intercellular communication. Animal experiments confirmed that SERINC2 protein levels are elevated in the lung tissues of BLM-induced mice, supporting its role in disease progression. Our findings suggest that SERINC2 may serve as a potential diagnostic biomarker and therapeutic target, providing new insights into the pathogenesis and potential treatment of IPF.

Read PDF

Similar papers

Open access Sep 2026

KLF2 as a prognostic and potential therapeutic target associated with ferroptosis in serous ovarian cancer: An integrative bioinformatics and clinical validation study

Findings indicate that KLF2 may serve as a prognostic and potential therapeutic target related to ferroptosis in serous ovarian cancer, warranting further investigation.

Yuan-Yi Wang, Ju-Zhou Yu, Wu Huang et al. · 0 citations
Oct 2026

Multi-omics integration reveals the CTSK-cholesterol metabolic axis and the cholesterol-RORA/LDLR paracrine axis in SPP1+ macrophages as mediators of 6PPD-quinone-induced idiopathic pulmonary fibrosis.

OBJECTIVE This study aimed to screen and identify potential biomarkers linking 6PPD-quinone (6PPD-Q) exposure to idiopathic pulmonary fibrosis (IPF), generating a mechanistic hypothesis for future experimental investigation and therapeutic development. METHODS 6PPD-Q-related genes and IPF-associated genes were obtain...

Qi-Xuan Wang, Yi-Ting Wu, Peng-Rui Du et al. · 0 citations
Sep 2026

Integrative multi-omics analysis identifies LIPA as a prognostic hub and ferroptosis regulator in lung adenocarcinoma.

Findings establish LIPA as a critical link between lipid metabolism, ferroptosis, and immune modulation in LUAD, and provide a prognostic signature for risk stratification as well as a candidate compound for targeting lipid metabolic vulnerabilities.

Fan Zhang, Shuai Han, Xiao-Dong Cao et al. · 0 citations
Open access Sep 2026

Multi-omics and machine learning-driven identification of PTM-related potential biomarkers and therapeutic insights in MASLD

Metabolic dysfunction-associated steatotic liver disease (MASLD) is biologically heterogeneous and lacks sufficiently validated molecular biomarkers for disease characterization. Post-translational modification (PTM)-related genes may link metabolic stress to lipid dysregulation and inflammation, but their relevance...

Qing-Rong Yao, Xuan-Chong Zhong, Jia-Wei Chen et al. · 0 citations
Open access Sep 2026

Multi-omics and machine learning reveal LYZ and ISG15 as diagnostic and therapeutic targets in autoimmune-mediated chronic kidney disease

Background CKD represents a substantial worldwide health challenge, defined by the gradual development of tubulointerstitial fibrosis and reduced renal performance. Autoimmune-mediated factors are central to this pathological process, yet early diagnostic biomarkers and specific therapeutic targets are scarce. The obje...

Haofeng Zheng, Jie-Yi Dong, Qing-Fu Dai et al. · 0 citations
Aug 2026

Multi-omics and experimental validation reveal the proliferative mechanism of ACSL4 in pulmonary hypertension and identify potential FDA-approved drugs via in silico screening.

BACKGROUND Pulmonary hypertension (PH) is a life-threatening blood vessel disorder marked by remodeling of the pulmonary arteries. A key feature of this process is the uncontrolled growth of pulmonary artery smooth muscle cells (PASMCs). Although changes in fatty acid metabolism are thought to drive this abnormal cell...

Wei Chen, Yi-Ting Dong, Qiong Shi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.